Economic Value Of Drugs Should Be Factor In FDA Approval, More Pharma Execs Say
This article was originally published in The Pink Sheet Daily
Executive Summary
PwC Health Research Institute’s survey of 100 senior executives found 43% support FDA use of economic data in deciding whether to approve a drug, up from 14% four years ago.